Neurodevelopmental Disorders: Clinical Trials

37 trials for Neurodevelopmental Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 unknown. 37 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 437Unknown 37

Follow Neurodevelopmental Disorders: new trials by email Literature Review of Neurodevelopmental Disorders trials Research Report on Neurodevelopmental Disorders

Trials (filtered) newest first · largest first

All 37 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FASST - Fetal Alcohol Spectrum Stimulant Trial
Methylphenidate Hydrochloride, Placebo, Methylphenidate hydrochloride - Fetal Alcohol Spectrum Disorders
Phase 4UnknownMonash Medical Centre202022-02-142022-12-13
Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder
Cariprazine - Attention Deficit Hyperactivity Disorder
Phase 4UnknownDr. Martin A. Katzman152021-12-012021-12-14
Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT
Therapeutic Drug Monitoring, Risperidone plasma level - Autism Spectrum Disorder
Phase 4UnknownErasmus Medical Center1402021-12-012023-12-08
The Effects of a Single Dose of Methylphenidate on Motor Performance
MPH - ADHD
Phase 4UnknownLoewenstein Hospital2002021-05-272023-12-20
Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,
Placebo, Sialanar, Oral Rehabilitation - Sialorrhea, Neurodevelopmental Disorders
Phase 4UnknownProveca Pharma Limited802021-05-102022-07-08
Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD
Placebos, vitamin AD, vitamin D - ADHD
Phase 4UnknownChen Li5042021-02-252021-04-06
Prenatal Iodine Supplementation and Early Childhood Neurodevelopment
Low Iodine Supplement, Standard Iodine Supplement - Pregnancy Related, Neurodevelopmental Disorders
Phase 4UnknownSouth Australian Health and Medical Research Institute7942021-01-182024-04-03
Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD
Foquest - Attention Deficit Hyperactivity Disorder
Phase 4UnknownJPM van Stralen Medicine Professional412020-12-012023-09-28
Melatonin in ADHD and Sleep Problems
Melatonin 3 mg - Attention Deficit Hyperactivity Disorder, Sleep Disorder
Phase 4UnknownAllan Hvolby802020-09-012022-05-09
Intranasal Dexmedetomidine vs Oral Triclofos Sodium for EEG in Children With Autism
Dexmedetomidine, Triclofos 100 MG/ML - Autistic Disorder
Phase 4UnknownRabin Medical Center2002020-03-012020-02-17
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Methylphenidate, Atomoxetine - ADHD, Attention Deficit Hyperactivity Disorder
Phase 4UnknownIcahn School of Medicine at Mount Sinai442019-06-042024-08-09
Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children
Methylphenidate - Attention Deficit Hyperactivity Disorder
Phase 4UnknownIRCCS Eugenio Medea202018-04-132022-08-05
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Methylphenidate - ADHD, Attention Deficit Hyperactivity Disorder
Phase 4UnknownIcahn School of Medicine at Mount Sinai5002018-03-042024-08-09
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
Aptensio XR - Attention Deficit Disorder With Hyperactivity
Phase 4UnknownRhodes Pharmaceuticals, L.P.1202016-09-012016-08-25
Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder
Rhodiola, Placebo - Attention Deficit/Hyperactivity Disorder
Phase 4UnknownHospital de Clinicas de Porto Alegre602016-04-012019-05-29
Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder
Rhodiola, Placebo - Attention Deficit Hyperactivity Disorder
Phase 4UnknownHospital de Clinicas de Porto Alegre602016-04-012019-05-29
A Comparison of Two Doses of Intranasal Dexmedetomidine for Premedication in Children
Dexmedetomidine - Anxiety, Separation
Phase 4UnknownThe University of Hong Kong1402015-06-012016-04-18
Effects of a Probiotic Supplement on Symptoms of Attention Deficit Hyperactivity Disorder and Anxiety in Children
L. helveticus R0052 and B. longum R0175, Placebo - Attention Deficit Hyperactivity Disorder, Anxiety
Phase 4UnknownAcadia University1002015-06-012015-09-10
Study to Evaluate the Efficacy and Safety of Aripiprazole
Aripiprazole - Autism
Phase 4UnknownYoo-Sook Joung792014-02-012014-03-11
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
Gammaplex 5% - Autism, Autistic Disorder
Phase 4UnknownIsaac Melamed302013-06-012015-04-16

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Attention Deficit Disorder with Hyperactivity (27)  ·  Autistic Disorder (4)  ·  Aggression (2)  ·  Sleep Wake Disorders (2)  ·  Anxiety Disorders (1)  ·  Anxiety, Separation (1)  ·  Asperger Syndrome (1)  ·  Autism Spectrum Disorder (1)  ·  Bipolar Disorder (1)  ·  Child Development Disorders, Pervasive (1)  ·  Conduct Disorder (1)  ·  Dyslexia (1)  ·  Epilepsy (1)  ·  Fetal Alcohol Spectrum Disorders (1)

Broader conditions

Mental Disorders (37)  ·  Attention Deficit and Disruptive Behavior Disorders (27)  ·  Nervous System Diseases (6)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Autism Spectrum Disorder (4)  ·  Behavior (4)  ·  Child Development Disorders, Pervasive (4)  ·  Aberrant Motor Behavior in Dementia (2)  ·  Anxiety Disorders (2)  ·  Behavioral Symptoms (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)

Interventions

Methylphenidate (14)  ·  Atomoxetine Hydrochloride (4)  ·  5,10-dihydro-5-methylphenazine (3)  ·  Dexmedetomidine (2)  ·  Dextroamphetamine (2)  ·  Melatonin (2)  ·  Amphetamine (1)  ·  Anticonvulsants (1)  ·  Aripiprazole (1)  ·  Choline (1)  ·  Diet, Ketogenic (1)  ·  Levodopa (1)  ·  Lisdexamfetamine Dimesylate (1)  ·  Rehabilitation (1)  ·  Risperidone (1)

Sponsors

Federal University of Rio Grande do Sul (2)  ·  Hospital de Clinicas de Porto Alegre (2)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Acadia University (1)  ·  Allan Hvolby (1)  ·  Assaf-Harofeh Medical Center (1)  ·  BRC Operations Pty. Ltd. (1)  ·  Chen Li (1)  ·  Dr. Martin A. Katzman (1)  ·  Erasmus Medical Center (1)  ·  Geha Mental Health Center (1)  ·  IRCCS Eugenio Medea (1)  ·  Isaac Melamed (1)  ·  JPM van Stralen Medicine Professional (1)  ·  Joseph Blader (1)

Countries

United States (7)  ·  Canada (5)  ·  Brazil (4)  ·  Israel (4)  ·  Australia (3)  ·  South Korea (3)  ·  China (2)  ·  France (2)  ·  Netherlands (2)  ·  Denmark (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Norway (1)  ·  Philippines (1)

Top investigators

Eugenio Grevet, PhD (2)  ·  Jeffrey Newcorn, MD (2)  ·  Alison Crichton, PhD (1)  ·  Allan Hvolby, MD, Ph.D (1)  ·  Ann Childress, MD (1)  ·  Barbara A. Cohen, PhD (1)  ·  Bjorn Bjurulf, MD (1)  ·  Boong-nyun Kim, MD, PhD (1)  ·  Chi-Yung Shang, M.D., Ph.D. (1)  ·  Claudia M Szobot, MD (1)  ·  Dorit Ben-Shalom, Ph.D (1)  ·  Harbans Multani, MD (1)  ·  Iliyan Ivanov, MD (1)  ·  Isaac Melamed, MD (1)  ·  Joseph C. Blader, PhD, MSc (1)

Results publications

PMID 12472704, PMID 17646493, PMID 18363626, PMID 21318594, PMID 21461792, PMID 21586916, PMID 21862817, PMID 22704249, PMID 22950484, PMID 24290461, PMID 24532346, PMID 24823763, PMID 25246305, PMID 26745211, PMID 26814037, PMID 26936022, PMID 28347608, PMID 28455770, PMID 29701730, PMID 29937325, PMID 30982953, PMID 31292919, PMID 31447530, PMID 31862730, PMID 32007604, PMID 33892111, PMID 34135055, PMID 36112116, PMID 36539734, PMID 37058600, PMID 3706808, PMID 37164467, PMID 37267443, PMID 37811711, PMID 38631835, PMID 40390018, PMID 40681145, PMID 41567292, PMID 42620964, PMID 8632499, PMID 9060867

NIH funding

R01HD093612 (1), R21DA045218 (1)